Company news
HemoGenyx Pharmaceuticals PLC news in 2022
HemoGenyx Pharmaceuticals PLC's news releases, calls and decks from 2022, newest first.
HEMO-CAR-T First PQ Run Completed
December 12, 2022
HEMO-CAR-T Process Development Runs Completed
November 18, 2022
Presentation at H.C. Wainwright Global Conference
September 1, 2022
Appointment of Director of Quality
August 22, 2022
Approval and Issuance of Antibody Patent
August 15, 2022
Appointment of Medical Director
August 10, 2022
New Custom R&D Facility Opening
July 13, 2022
Investor Webinar Recording
July 8, 2022
Change of Registered Office
July 1, 2022
Investor Webinar
June 27, 2022
Director/PDMR Shareholding
May 30, 2022
Immuno-Oncology Summit Europe Presentation
May 16, 2022
Final Results for the Year Ended 31 December 2021
April 29, 2022
CBR Update
March 16, 2022
HEMO-CAR-T pre-IND Meeting Request
February 16, 2022
Hemogenyx Pharmaceuticals Partnership with Selexis
January 12, 2022
H.C. Wainwright Bioconnect Conference
January 5, 2022